PDGFRβ-targeted positron emission tomography (PET) has a great potential as an imaging biomarker for assessing disease progression and treatment responses in multiple liver fibrosis etiologies, including viral hepatitis (HBV, HCV) [15]. This evidence concerns the gene PDGFRB and Hepatic fibrosis.